Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
Depression is the leading cause of suicide, and antidepressants and modified electroconvulsive therapy (mECT) are the preferred treatment modalities. Ketamine is an established anesthetic agent and evidence for its use in depression is evolving. Here, we discuss the experience of treating severe dep...
Saved in:
Main Authors: | T. V. Pavan Kumar, Divya Bolla, Raj Kiran Donthu, Anzory Pathak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Annals of Indian Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/aip.aip_212_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01) -
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
by: Moaz Yasser Darwish, et al.
Published: (2025-02-01) -
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01) -
Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression
by: Kasper Recourt, et al.
Published: (2025-02-01) -
The blues and rhythm
by: Kiyomichi Imamura, et al.
Published: (2025-02-01)